Change in the Supervisory Board at aap Implantate AG

(PresseBox) ( Berlin, )
aap Implantate AG ("aap") announces that Ronald Meersschaert will resign from his office as a member of the Supervisory Board for personal reasons. His duties will conclude on 5 October 2016. Ronald Meersschaert was first elected as a member of aap's Supervisory Board by the annual general meeting in financial year 2009. His successor will be Ms. Jacqueline Rijsdijk (60), who was elected as a substitute member for Mr. Meersschaert. Jacqueline Rijsdijk is a Board Advisor in the Netherlands and member of several Supervisory Boards and control committees of reputable companies such as Deloitte Netherlands and Royal Cosun.

Biense Visser, Chairman of the Supervisory Board at aap, praises the work of Ronald Meersschaert over the past years: "We thank Ronald Meersschaert for his great commitment and the outstanding work for aap on the way to a focused trauma company in recent years. As a recognised financial expert and seasoned investor, he was always a competent and trusted contact for the Supervisory and Management Boards and made a significant contribution in both financial and strategic matters."

In addition Biense Visser welcomes Jacqueline Rijsdijk’s acceptance of the Supervisory Board mandate: “Jacqueline Rijsdijk is a regarded Board Advisor with comprehensive economic and financial knowledge and an excellent network. We are very much looking forward to our cooperation and are sure that aap will benefit from her distinctive financial expertise and many years of experience.”
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to